| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0812
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04 |
| filingDate |
2006-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3bbe639ad4955c37e11e357b1b5a88e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9bfe32a0a06b39078ee56058faf1081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf52d8cc8b0f92899a6c300fdac90b1d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92aeb8cc8b4584ce1dac9f4856c63591
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45bb795d16d27f86f985f78ada5868e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2117788afa0d717ba0ed97b515d75e40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2edaaed4df10f67233e1affd8d8cc7ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4c1a911f8c42468f0400a8a95f0ef2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe9f8599102c15c9a751be8a3e2dd948 |
| publicationDate |
2012-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2006220708-B2 |
| titleOfInvention |
Process for preparing macrocyclic compounds |
| abstract |
Disclosed is a process for preparing a macrocyclic compound of the formula (I) wherein a hydroxyl-substituted macrocyclic compound of formula (3) is reacted with a sulfonyl-substituted compound of formula QUIN. The compounds of formula (I) are potent active agents for the treatment of hepatitis C virus (HCV) infection. |
| priorityDate |
2005-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |